| Income Statement |
| Total Revenue | 76.70M |
|
| Revenues (USD) | 76.70M |
| Cost of Revenue | 45.20M |
| Gross Profit | 31.50M |
| Operating Expenses | 30.70M |
| Research and Development Expense | 18.90M |
| Selling, General and Administrative Expense | 10.00M |
| Operating Income | 800.00K |
| Interest Expense | 4.00M |
| Income Tax Expense | 2.50M |
| Net Income | 10.00M |
| Net Income Common Stock | 10.00M |
| Net Income Common Stock (USD) | 10.00M |
| Consolidated Income | 10.00M |
| Earnings per Basic Share | 0.51 |
| Earnings per Basic Share (USD) | 0.51 |
| Earnings per Diluted Share | 0.45 |
| Earning Before Interest & Taxes (EBIT) | 16.50M |
| Earning Before Interest & Taxes (USD) | 16.50M |
| Weighted Average Shares | 19.77M |
| Weighted Average Shares Diluted | 22.45M |
| Balance Sheet |
| Cash and Equivalents | 1.87B |
| Cash and Equivalents (USD) | 1.87B |
| Trade and Non-Trade Receivables | 41.80M |
| Current Assets | 2.30B |
| Property, Plant & Equipment Net | 59.50M |
| Total Assets | 2.43B |
| Debt Current | 2.50M |
| Total Debt | 1.18B |
| Current Liabilities | 401.30M |
| Debt Non-Current | 1.18B |
| Total Liabilities | 1.66B |
| Accumulated Retained Earnings (Deficit) | 11.50M |
| Accumulated Other Comprehensive Income | -700.00K |
| Shareholders Equity | 775.20M |
| Shareholders Equity (USD) | 775.20M |
| Assets Non-Current | 137.80M |
| Total Debt (USD) | 1.18B |
| Deferred Revenue | 112.80M |
| Goodwill and Intangible Assets | 19.40M |
| Inventory | 336.00M |
| Liabilities Non-Current | 1.26B |
| Trade and Non-Trade Payables | 49.50M |
| Tax Assets | 19.50M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 2.20M |
| Net Cash Flow from Financing | -300.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -58.90M |
| Capital Expenditure | -23.20M |
| Net Cash Flow from Investing | -23.20M |
| Net Cash Flow from Operations | -35.10M |
| Effect of Exchange Rate Changes on Cash | -300.00K |
| Share Based Compensation | 400.00K |